VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CDLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CDLXCardlytics, Inc.
$4.87$28M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCDLXBalance Sheet

Cardlytics, Inc. (CDLX) Balance Sheet

11Y historyFree accessUpdated daily

The company's financial position is increasingly fragile, characterized by a negative equity balance of -$4.0M and a substantial debt load of $210.0M as of 2026Q1.

CDLX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Total Current Assets128.52M137.28M177.98M223.93M250.04M358.73M385.59M195.73M124.37M74.63M68.32M68.08M
Cash & Short-Term Investments59.8M48.72M65.59M91.83M121.91M233.47M293.24M104.46M39.62M21.26M22.84M27.32M
Cash Only35.67M48.72M65.59M91.83M121.91M233.47M293.24M104.46M39.62M21.26M22.84M27.32M
Short-Term Investments24.13M00000000000
Accounts Receivable65.75M85.26M107.05M126M120.08M117.18M86.56M85.36M60.54M51.25M43.82M39.13M
Days Sales Outstanding150.4133.4140.4148.74146.81160.12169.04148.06146.65143.48141.75183.95
Inventory0000000020.25M0130K286K
Days Inventory Outstanding--------76.98-0.661.99
Other Current Assets2.97M3.3M5.34M6.1M8.06M95K110K129K20.25M2.12M130K286K
Total Non-Current Assets135.39M148.36M214.73M350.22M441.19M905.07M36.95M28.58M29.39M26.13M18.54M14.21M
Property, Plant & Equipment6.15M6.97M8.94M10.63M12.49M21.47M24.63M14.29M10.23M7.32M8.35M9.55M
Fixed Asset Turnover29.73x33.46x31.14x29.08x23.91x12.44x7.59x14.73x14.73x17.81x13.52x8.13x
Goodwill110.31M110.31M159.43M277.2M352.72M742.52M000000
Intangible Assets17.78M5.55M11.37M59.65M73.4M138.68M6.75M4.2M2M961K476K1.09M
Long-Term Investments000000000000
Other Non-Current Assets1.16M25.53M34.99M2.73M2.59M2.41M5.57M10.09M17.17M17.85M9.71M3.56M
Total Assets263.91M285.64M392.71M574.14M691.24M1.26B422.54M224.31M153.76M100.76M86.86M82.29M
Asset Turnover0.68x0.82x0.71x0.54x0.43x0.21x0.44x0.94x0.98x1.29x1.30x0.94x
Asset Growth %-114.86%-27.26%-31.6%-16.94%-45.3%199.1%88.37%45.88%52.61%16%5.55%-
Total Current Liabilities59.35M78.39M148.96M171.15M248.94M327.35M81.27M78.4M51.92M42.14M39.6M67.26M
Accounts Payable2.6M3.36M3.69M4.42M3.77M4.62M1.36M1.23M2.1M1.55M2.37M4.38M
Days Payables Outstanding9.639.578.559.037.3910.294.023.427.987.0711.9430.43
Short-Term Debt0045.86M10K000021K44K022.03M
Deferred Revenue (Current)11.8M2.59M2.15M2.4M1.75M3.28M349K1.13M346K132K638K566K
Other Current Liabilities4.57M6.11M10.06M150.52M114.61M194.61M7.58M8.19M43.52M4.59M23.75M21.33M
Current Ratio2.17x1.75x1.19x1.31x1.00x1.10x4.74x2.50x2.40x1.77x1.73x1.01x
Quick Ratio2.17x1.75x1.19x1.31x1.00x1.10x4.74x2.50x2.01x1.77x1.72x1.01x
Cash Conversion Cycle140.77-------215.65-130.47155.51
Total Non-Current Liabilities208.56M213.76M173.76M268.2M230.69M245.75M184.07M2.65M49.87M267.31M264.09M177.19M
Long-Term Debt204.2M208.92M167.73M257.58M226.05M184.4M174.01M046.69M56.91M111.7M9.82M
Capital Lease Obligations19.24M4.79M6.03M6.39M4.31M6.8M9.38M13K37K57K101K64K
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities0004.16M054.38M679K2.63M3.14M210.34M152.29M167.31M
Total Liabilities267.91M292.15M322.72M439.35M479.63M573.1M265.35M81.05M101.79M309.44M303.69M244.45M
Total Debt210.03M215.31M221.65M266.11M235.26M197.23M188.11M37K46.71M57.01M111.9M32.26M
Net Debt174.35M166.59M156.06M174.28M113.36M-36.24M-105.13M-104.42M7.09M35.75M89.06M4.94M
Debt / Equity-52.47x-3.17x1.97x1.11x0.29x1.20x0.00x0.90x---
Debt / EBITDA-3.03x-----------
Net Debt / EBITDA-2.52x-----------
Interest Coverage-8.41x-8.74x-20.26x-20.79x-116.21x-9.63x-15.02x-12.05x-15.25x-1.37x-4.92x-26.71x
Total Equity-4M-6.51M69.99M134.8M211.6M690.7M157.19M143.27M51.98M-208.69M-216.84M-162.16M
Equity Growth %-394.34%-109.3%-48.08%-36.3%-69.36%339.4%9.72%175.65%124.91%3.76%-33.72%-
Book Value per Share-0.73-1.2314.4736.9463.32214.4957.7660.3327.27-106.91-154.58-758.38
Total Shareholders' Equity-4M-6.51M69.99M134.8M211.6M690.7M157.19M143.27M51.98M-208.69M-216.84M-162.16M
Common Stock10K10K10K9K9K9K8K8K7K01K1K
Retained Earnings-1.41B-1.4B-1.3B-1.11B-976.57M-522.62M-394.05M-338.63M-321.49M-268.44M-248.8M-173.11M
Treasury Stock000000000000
Accumulated OCI-532K-2M3.6M2.47M5.6M486K-192K1.31M1.99M1.07M2.1M583K
Minority Interest000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity exhaustion and insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Eroding Equity Base Signals Distress

As reported in recent financial statements, the company's equity position has deteriorated into negative territory, falling to -$4.0M in 2026Q1 from a peak of $210.0M in 2024Q2, which underscores a rapid depletion of shareholder value driven by persistent net losses and ongoing operational cash burn.

The shift to negative equity suggests that the company's accumulated losses have now fully offset its capital base, raising significant questions regarding long-term solvency. Investors should monitor whether this trajectory necessitates further dilutive financing or restructuring to stabilize the balance sheet.

Cash Runway Nearing Critical Thresholds

Based on the company's reported figures, cash reserves have declined to $35.7M in 2026Q1, down from $97.8M in 2024Q1, indicating a tightening liquidity buffer that may struggle to support ongoing operations if the current rate of cash consumption persists without a meaningful improvement in revenue.

While the current ratio of 2.17 appears superficially healthy, the absolute decline in cash balances relative to the company's high fixed-cost structure warrants caution. The narrowing gap between available liquidity and operational requirements suggests that the firm may face increasing pressure to secure external funding in the near term.

Intangible Asset Concentration Risks Valuation

According to recent SEC filings, goodwill remains a significant component of the asset base at $110.3M, representing a substantial portion of the $263.9M total assets, which implies that the company's book value is highly sensitive to potential impairment charges if business performance continues to decline.

The heavy reliance on intangible assets, largely stemming from past acquisitions, suggests that the balance sheet may be overstating the tangible value of the firm. If the core platform fails to regain growth momentum, the risk of a material goodwill write-down could further impair the already fragile equity position.

Hidden Leverage Through Debt Obligations

As evidenced by the company's balance sheet data, total debt remains elevated at $210.0M as of 2026Q1, a figure that dwarfs the company's cash position and highlights a precarious leverage profile that limits financial flexibility during this period of sustained revenue contraction.

The presence of significant debt in the absence of positive free cash flow creates a structural vulnerability that could restrict the company's ability to pivot its strategy. Investors should consider the potential for debt covenants to be triggered if operating performance does not align with the expectations of creditors.

CDLX — Frequently Asked Questions

Quick answers to the most common questions about buying CDLX stock.

What are the total assets of Cardlytics, Inc. (CDLX)?

As of 2025, Cardlytics, Inc. (CDLX) had total assets of $285.6M including $137.3M in current assets.

How much debt does Cardlytics, Inc. (CDLX) have?

Cardlytics, Inc. (CDLX) carries total debt of $215.3M, offset by $48.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cardlytics, Inc.?

Cardlytics, Inc. (CDLX) has total shareholders' equity (book value) of $-6.5M ($-1.23 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cardlytics, Inc.'s current ratio and liquidity?

Cardlytics, Inc. (CDLX) reported a current ratio of 1.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.